Harrow (HROW) Cash from Operations (2010 - 2026)
Harrow's (HROW) quarterly Cash from Operations came in at 8992000.0 in Q1 2026, down 145.72% year-on-year from 19668000.0 in Q1 2025, and down 206.91% quarter-over-quarter from 8411000.0 in Q4 2025.
Harrow (HROW) Cash from Operations (2010 - 2026) Analysis & Trends
Harrow's Cash from Operations history runs 17 years deep, the most recent figure standing at 8992000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 145.72% year-over-year to 8992000.0 in Q1 2026; TTM through Mar 2026 was 15204000.0, a 626.07% increase from a year earlier, with the FY2025 full-year figure at 43864000.0, up 297.57% from the prior year.
- Cash from Operations declined to 8992000.0 in Q1 2026 per HROW's latest filing, from 8411000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 19668000.0 in Q1 2025 and bottomed at 17779000.0 in Q4 2024.
- The 5-year median for Cash from Operations is 410000.0 (2022), against an average of 1071470.59.
- Across the five-year window, Cash from Operations plunged 949.43% in 2023 and jumped 524.98% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 3712000.0 in 2022, then surged by 334.27% to 8696000.0 in 2023, then slumped by 304.45% to 17779000.0 in 2024, then surged by 147.31% to 8411000.0 in 2025, then sank by 206.91% to 8992000.0 in 2026.
- Per Business Quant, the three latest HROW Cash from Operations figures stand at 8992000.0 (Q1 2026), 8411000.0 (Q4 2025), and 16588000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | -8.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.99 Mn |
| Mar 31, 2026 | -8.99 Mn |
| Dec 31, 2025 | 8.41 Mn |
| Dec 31, 2025 | 8.41 Mn |
| Sep 30, 2025 | 16.59 Mn |
| Sep 30, 2025 | 16.59 Mn |
| Jun 30, 2025 | -803,000.00 |
| Jun 30, 2025 | -803,000.00 |
| Mar 31, 2025 | 19.67 Mn |
| Mar 31, 2025 | 19.67 Mn |
| Dec 31, 2024 | -17.78 Mn |
| Dec 31, 2024 | -17.78 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | -2.75 Mn |
| Jun 30, 2024 | -2.75 Mn |
| Mar 31, 2024 | -4.63 Mn |
| Mar 31, 2024 | -4.63 Mn |
| Dec 31, 2023 | 8.70 Mn |
| Dec 31, 2023 | 8.70 Mn |